Impact of Timing of Wound Dressing Removal After Cesarean Section
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02445729 |
Recruitment Status :
Completed
First Posted : May 15, 2015
Last Update Posted : November 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Abdominal Wall Wound | Other: Dressing removal at 24 hours Other: Dressing removal at 48 hours | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 869 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Impact of Timing of Wound Dressing Removal After Cesarean Section: Effect of Dressing Removal at 24 Hours Versus 48 Hours on Wound Healing and Incidence of Surgical Site Infections Following Cesarean Section |
Actual Study Start Date : | March 2015 |
Actual Primary Completion Date : | February 2017 |
Actual Study Completion Date : | January 31, 2019 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Dressing Removal at 24 Hours
These patients are randomly assigned to have their dressing removed 24 hours after cesarean section.
|
Other: Dressing removal at 24 hours
Dressing will be removed 24 hours after cesarean section and wounds will be assessed for healing and presence of infection. |
Active Comparator: Dressing Removal at 48 Hours
These patients are randomly assigned to have their dressing removed 48 hours after cesarean section.
|
Other: Dressing removal at 48 hours
Dressing will be removed 48 hours after cesarean section and wounds will be assessed for healing and presence of infection. |
- ASEPSIS Wound Score (1-day) [ Time Frame: 24 or 48 Hours Postoperative ]
- ASEPSIS Wound Score (1-day) [ Time Frame: 1 Week Follow-Up ]
- ASEPSIS Wound Score (1-day) [ Time Frame: 6 Week Follow-Up ]
- Patients' satisfaction [ Time Frame: 24 or 48 Hours Postoperative ]
- Patients' satisfaction [ Time Frame: 1 Week Follow-Up ]
- Patients' satisfaction [ Time Frame: 6 Week Follow-Up ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 44 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- low-risk obstetric patients aged 18-44 years with term, singleton pregnancies who planned to have Cesarean Delivery (CD).
CD indications:
- Scheduled nonlabored primary CD for fetal malpresentation,
- Suspected macrosomia,
- Maternal request,
- Placental anomaly,
- Abnormal / indeterminate fetal heart tracing without labor.
- First, second, and third repeat CDs will be included.
Exclusion Criteria:
- Preeclampsia,
- Preeclampsia with severe features,
- Eclampsia,
- Known preoperative infectious disease, any unknown origin preoperative fever,
- Diabetes,
- Pregnant with premature rupture of membrane (PROM) or rupture of membrane (ROM),
- Intraoperative findings suggestive of an underlying cancerous condition,
- Vertical skin incision,
- Planned hysterectomy during CD.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02445729
United States, Texas | |
University of Texas Medical Branch at Galveston | |
Galveston, Texas, United States, 77550 | |
Turkey | |
Etlik Zübeyde Hanim Women's Health Training and Research Hospital | |
Ankara, Turkey, 06010 | |
Dicle University | |
Diyarbakır, Turkey, 21280 |
Principal Investigator: | Gokhan S Kilic, MD | University of Texas Medical Branch at Galveston |
Responsible Party: | The University of Texas Medical Branch, Galveston |
ClinicalTrials.gov Identifier: | NCT02445729 |
Other Study ID Numbers: |
14-0548 |
First Posted: | May 15, 2015 Key Record Dates |
Last Update Posted: | November 10, 2020 |
Last Verified: | June 2019 |
Cesarean Section Wound Healing |
Wounds and Injuries |